Towards Next Generation Adenosine A2A Receptor Antagonists

Author(s): G. Yuan, G.B. Jones

Journal Name: Current Medicinal Chemistry

Volume 21 , Issue 34 , 2014

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


The Adenosine A2A receptor is a member of the G-protein coupled receptor superfamily. It plays a key role in numerous physiological processes through the central nervous system and in peripheral tissues. Functional interactions between the A2A and dopamine D2 receptor has spurred interest in the use of antagonists as anti-Parkinson drugs. Additionally, oncology drugs are now being designed based on the potential for A2A antagonists to function as immunotherapeutics. From early studies based on classical xanthine type A2A antagonists through second generation agents, this mini review will cover aspects of the discovery, development, chemical synthesis and medicinal evaluation of this important class of drugs.

Keywords: A2AR antagonists, aqueous solubility, cancer immunotherapy, molecular modeling, parkinson's disease, PET imaging, X-ray crystallography.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [3918 - 3935]
Pages: 18
DOI: 10.2174/0929867321666140826115123
Price: $65

Article Metrics

PDF: 78